Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Federal Appeals Court Returns Zantac Cancer Lawsuits Back To Connecticut State Court Judges noted that the nine Zantac lawsuits involving more than 850 plaintiffs were structured in a way to avoid the need for the cases to be handled at the federal level, where all similar claims have been dismissed. July 25, 2024 Irvin Jackson Add Your Comments The U.S. Court of Appeals for the Second Circuit has determined that nine lawsuits filed against the manufacturers of Zantac, which involve claims brought by more than 850 people who developed cancer after using the recalled heartburn drug, should be remanded back to Connecticut state court for continued handling, determining that the claims are not subject to federal jurisdiction. The cases represent only a small fraction the Zantac cancer lawsuits currently being pursued against various different pharmaceutical companies, each raising similar allegations that consumers were not adequately warned about the risk that the active ingredient ranitidine is inherently unstable and produces high levels of the chemical byproduct N-Nitrosodimethylamine (NDMA), which is a potent human carcinogen. A massive Zantac recall was issued in 2020, removing all versions of brand name and generic ranitidine from the market, and drug makers continue to face claims being pursued by former users who developed bladder cancer, liver cancer, pancreatic cancer, stomach cancer and other injuries after taking the medication to treat heartburn or acid reflux. ZANTAC LAWSUITS Did you or a loved one take recalled Zantac? Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ZANTAC LAWSUITS Did you or a loved one take recalled Zantac? Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The Zantac litigation was initially focused in the federal court system, where claims brought in U.S. District Courts nationwide were centralized before U.S. District Judge Robin L. Rosenberg for coordinated discovery and pretrial proceedings. However, before the first case ever reached trial, Judge Rosenberg issued a controversial ruling excluding all of the plaintiffs’ expert witness testimony, which was needed to establish that Zantac causes cancer. Judge Rosenberg’s decision was based on an interpretation of the federal rules regarding the admissibility of expert testimony, resulting in the dismissal of all federal Zantac lawsuits. However, the ruling had no impact on tens of thousands of claims now being pursued in various different state court systems, including Illinois, Delaware and Connecticut, where different standards for the admissibility of expert witness testimony. Zantac Cancer Lawsuit Remand Ruling Upheld In the aftermath of the ruling, plaintiffs called for a group of nine Zantac cancer lawsuits, representing more than 850 plaintiffs, to be remanded from the federal court back to the state court in Connecticut, where they were originally filed. Plaintiffs argued that their claims were improperly removed to the federal court system, and should be adjudicated at the state level. Defendants pushed back, maintaining that the lawsuits should be litigated in the federal court system based on the consolidated nature of the claims and provisions of The Class Action Fairness Act, which expands federal subject-matter jurisdiction to “mass actions” in which damages are sought by 100 or more individuals seeking a joint trial. However, on Tuesday, the U.S. Court of Appeals for the Second Circuit issued an opinion (PDF) supporting plaintiffs’ remand of the claims to state court. The appeals court noted that plaintiffs had structured their lawsuits in a way that was clearly, and legally, designed to avoid the need for the cases to be adjudicated at the federal level. “In this case, which involves nine virtually identical cases filed in Connecticut state court, Plaintiffs sought to do just this. They went to great lengths to evade various triggers of federal subject-matter jurisdiction,” the appeals court noted, in a 2-1 ruling. “Time and again, Plaintiffs walked the edge of one jurisdictional line or another, and each time they sought to avoid missteps that might allow the cases to be brought into federal court.” They determined that a ruling in federal court which remanded the claims back to state court was the correct ruling, and affirmed the decision. July 2024 Zantac Lawsuit Update While all federal Zantac lawsuits have been dismissed, and are currently pending on appeal, various drug makers have taken differing approaches to defending remaining cases pending at the state court level. Pfizer and Sanofi recently announced a Zantac settlement agreements to resolve thousands of claims involving their role in the sale of the medication, while GlaxoSmith Kline and Boehringer Ingelheim have continued to defend the litigation, only reaching one-off agreements to resolve individual claims on the eve of trial. However, one case against those drug makers recently went to trial in Illinois, resulting in a defense verdict. In Delaware state court, where the majority of remaining claims are currently pending, the judge presiding over the litigation recently cleared 75,000 Zantac lawsuits to move forward, after finding that plaintiffs’ expert witness testimony was sufficiently reliable for a jury to consider the claims. Tags: Boehringer Ingelheim, Cancer, Connecticut, GlaxoSmithKline, Heartburn, Heartburn Drug, NDMA, Sanofi, Zantac, Zantac Recall Image Credit: Atomazul More Zantac Lawsuit Stories Jury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim February 5, 2025 Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California November 22, 2024 GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers October 10, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: today) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025) Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 3 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (Posted: 4 days ago) A Mississippi woman’s Ozempic lawsuit indicates that she suffered stomach paralysis due to the drug’s delayed gastric emptying side effects, which left her with permanent injuries. MORE ABOUT: OZEMPIC LAWSUITCourt Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)
GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers October 10, 2024
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: today) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 3 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer.
Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (Posted: 4 days ago) A Mississippi woman’s Ozempic lawsuit indicates that she suffered stomach paralysis due to the drug’s delayed gastric emptying side effects, which left her with permanent injuries. MORE ABOUT: OZEMPIC LAWSUITCourt Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)